These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15910488)

  • 1. Antioxidant levels in peripheral blood, disease activity and fibrotic stage in chronic hepatitis C.
    Bandara P; George J; McCaughan G; Naidoo D; Lux O; Salonikas C; Kench J; Byth K; Farrell GC
    Liver Int; 2005 Jun; 25(3):518-26. PubMed ID: 15910488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum and liver micronutrient antioxidants and serum oxidative stress in patients with chronic hepatitis C.
    Yadav D; Hertan HI; Schweitzer P; Norkus EP; Pitchumoni CS
    Am J Gastroenterol; 2002 Oct; 97(10):2634-9. PubMed ID: 12385452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic glutathione deficiency in chronic hepatitis C: quantitative evaluation in patients who are HIV positive and HIV negative and correlations with plasmatic and lymphocytic concentrations and with the activity of the liver disease.
    Barbaro G; Di Lorenzo G; Soldini M; Parrotto S; Bellomo G; Belloni G; Grisorio B; Barbarini G
    Am J Gastroenterol; 1996 Dec; 91(12):2569-73. PubMed ID: 8946988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum adipokine levels in chronic liver diseases: association of resistin levels with fibrosis severity.
    Tsochatzis E; Papatheodoridis GV; Hadziyannis E; Georgiou A; Kafiri G; Tiniakos DG; Manesis EK; Archimandritis AJ
    Scand J Gastroenterol; 2008; 43(9):1128-36. PubMed ID: 18609175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antinuclear antibody is associated with a more advanced fibrosis and lower RNA levels of hepatitis C virus in patients with chronic hepatitis C.
    Hsieh MY; Dai CY; Lee LP; Huang JF; Tsai WC; Hou NJ; Lin ZY; Chen SC; Wang LY; Chang WY; Chuang WL; Yu ML
    J Clin Pathol; 2008 Mar; 61(3):333-7. PubMed ID: 17545561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of antioxidant supplementation on hepatitis C viral load, transaminases and oxidative status: a randomized trial among chronic hepatitis C virus-infected patients.
    Groenbaek K; Friis H; Hansen M; Ring-Larsen H; Krarup HB
    Eur J Gastroenterol Hepatol; 2006 Sep; 18(9):985-9. PubMed ID: 16894312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R; Asselah T; Cazals-Hatem D; Voitot H; Boyer N; Ripault MP; Sobesky R; Martinot-Peignoux M; Maylin S; Nicolas-Chanoine MH; Paradis V; Vidaud M; Valla D; Bedossa P; Marcellin P
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural history of hepatic fibrosis progression in chronic hepatitis C virus infection in India.
    Hissar SS; Kumar M; Tyagi P; Goyal A; Suneetha PV; Agarwal S; Rastogi A; Sakhuja P; Sarin SK
    J Gastroenterol Hepatol; 2009 Apr; 24(4):581-7. PubMed ID: 19032460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum hepcidin levels are related to the severity of liver histological lesions in chronic hepatitis C.
    Tsochatzis E; Papatheodoridis GV; Koliaraki V; Hadziyannis E; Kafiri G; Manesis EK; Mamalaki A; Archimandritis AJ
    J Viral Hepat; 2010 Nov; 17(11):800-6. PubMed ID: 20002304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data.
    Leandro G; Mangia A; Hui J; Fabris P; Rubbia-Brandt L; Colloredo G; Adinolfi LE; Asselah T; Jonsson JR; Smedile A; Terrault N; Pazienza V; Giordani MT; Giostra E; Sonzogni A; Ruggiero G; Marcellin P; Powell EE; George J; Negro F;
    Gastroenterology; 2006 May; 130(6):1636-42. PubMed ID: 16697727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E; Marchesini G; Gentilcore E; Cua IH; Vanni E; Rizzetto M; George J
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated liver stellate cells in chronic viral C hepatitis: histopathological and immunohistochemical study.
    Tomanovic NR; Boricic IV; Brasanac DC; Stojsic ZM; Delic DS; Brmbolic BJ
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):163-7. PubMed ID: 19565045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of fibrosis progression in untreated irish women with chronic hepatitis C contracted from immunoglobulin anti-D.
    Levine RA; Sanderson SO; Ploutz-Snyder R; Murray F; Kay E; Hegarty J; Nolan N; Kelleher D; McDonald G; O'Keane JC; Crowe J
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1271-7. PubMed ID: 16901770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antioxidant intake, plasma antioxidants and oxidative stress in a randomized, controlled, parallel, Mediterranean dietary intervention study on patients with rheumatoid arthritis.
    Hagfors L; Leanderson P; Sköldstam L; Andersson J; Johansson G
    Nutr J; 2003 Jul; 2():5. PubMed ID: 12952549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lowered plasma vitamin C, but not vitamin E, concentrations in dementia patients.
    Charlton KE; Rabinowitz TL; Geffen LN; Dhansay MA
    J Nutr Health Aging; 2004; 8(2):99-107. PubMed ID: 14978605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating level of large splice variants of tenascin-C is a marker of piecemeal necrosis activity in patients with chronic hepatitis C.
    Tanaka H; El-Karef A; Kaito M; Kinoshita N; Fujita N; Horiike S; Watanabe S; Yoshida T; Adachi Y
    Liver Int; 2006 Apr; 26(3):311-8. PubMed ID: 16584393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors for hepatitis C fibrosis: a prospective study of United States veterans compared with nonveterans.
    Kayali Z; Tan S; Shinkunas L; Voigt M; LaBrecque DR; Stapleton JT; Brown KE; Schmidt WN
    J Viral Hepat; 2007 Jan; 14(1):11-21. PubMed ID: 17212639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration.
    Moriarty-Craige SE; Adkison J; Lynn M; Gensler G; Bressler S; Jones DP; Sternberg P
    Am J Ophthalmol; 2005 Dec; 140(6):1020-6. PubMed ID: 16376645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between antioxidant status, markers of oxidative stress and immune responses in allergic adults.
    Dunstan JA; Breckler L; Hale J; Lehmann H; Franklin P; Lyons G; Ching SY; Mori TA; Barden A; Prescott SL
    Clin Exp Allergy; 2006 Aug; 36(8):993-1000. PubMed ID: 16911355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.